Skip to main content

Theravance Biopharma, Inc.

TBPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583107

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

Members of Congress who traded TBPH

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
1
Filings
1
Members
1
Buys / sells
0 / 1
Estimated volume
$32.5K
Sum of range midpoints
Members of Congress who traded TBPH
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
George WhitesidesDemocrat · House · CA10 / 1$32.5KMar 24, 2025Apr 23, 2025

Trades

Every reported trade in Theravance Biopharma, Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
George WhitesidesDemocrat · House · CATBPHTheravance Biopharma, Inc. - Ordinary SharesSellSelfMar 24, 2025Apr 23, 202530 days$15K-$50KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.